Menu
Explore Our Trials
Gateway for Cancer Research is one of the only nonprofits that exclusively funds innovative Phase I and Phase II cancer clinical trials for patients of all ages, regardless of cancer type. At the forefront of research and discovery, these early-phase trials are the first step in evaluating new cancer drugs, treatments, and therapies.
Results 11-20 of 46
Solid Tumors
Exercise Therapy as Preoperative Treatment for Solid Tumors (PRESTO)
Exercise Therapy as Preoperative Treatment for Solid Tumors (PRESTO) More information to come. Trial Registration: ClinicalTrials.gov Identifier: NCT03813615 For Researchers ImpactTODAY Newsletters Model of Support Gateway’s Impact Funded Clinical Trials Discovery Grant Apply for a Grant Research FAQ More for you Make a Tribute Gift Read Gateway News View Clinical Trials
Lee Jones, PhD
Memorial Sloan Kettering Cancer Center
Solid Tumors
EphA2 Gene Targeting using Neutral Liposomal Small Interfering RNA Delivery
EphA2 Gene Targeting using Neutral Liposomal Small Interfering RNA Delivery More information to come. Trial Registration: ClinicalTrials.gov Identifier: NCT01591356 For Researchers ImpactTODAY Newsletters Model of Support Gateway’s Impact Funded Clinical Trials Discovery Grant Apply for a Grant Research FAQ More for you Make a Tribute Gift Read Gateway News View Clinical Trials
Aung Naing, MD
MD Anderson Cancer Center
Lung Cancer
Phase 2 trial of the fatty acid synthase (FASN) inhibitor TVB-2640 for advanced KRAS mutant non-small cell lung cancer (NSCLC)
Phase 2 trial of the fatty acid synthase (FASN) inhibitor TVB-2640 for advanced KRAS mutant non-small cell lung cancer (NSCLC) More information to come. Trial Registration: ClinicalTrials.gov Identifier: NCT03808558 For Researchers ImpactTODAY Newsletters Model of Support Gateway’s Impact Funded Clinical Trials Discovery Grant Apply for a Grant Research FAQ More for you Make a Tribute […]
David Gerber, MD
University of Texas Southwestern Medical Center
Brain Cancer
Pharmacological ascorbate combined with radiation and temozolomide in GBM
Pharmacological ascorbate combined with radiation and temozolomide in GBM More information to come. Trial Registration: ClinicalTrials.gov Identifier: NCT042344355 For Researchers ImpactTODAY Newsletters Model of Support Gateway’s Impact Funded Clinical Trials Discovery Grant Apply for a Grant Research FAQ More for you Make a Tribute Gift Read Gateway News View Clinical Trials
Bryan Allen, MD, PhD
University of Iowa
Brain Cancer
A Phase 1 Study of M032 (NSC 733972), a Genetically Engineered HSV-1 Expressing IL- 12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma
A Phase 1 Study of M032 (NSC 733972), a Genetically Engineered HSV-1 Expressing IL- 12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma More information to come. Trial Registration: ClinicalTrials.gov Identifier: NCT03657576 For Researchers ImpactTODAY Newsletters Model of Support Gateway’s Impact Funded Clinical Trials Discovery Grant Apply for a Grant Research FAQ More […]
James Markert, MD, MPH
University of Alabama at Birmingham
Cervical Cancer
Development of an LMIC-adapted Thermoablation Prototype and Treatment Protocol for Cervical Pre-Cancer
Development of an LMIC-adapted Thermoablation Prototype and Treatment Protocol for Cervical Pre-Cancer More information to come. Trial Registration: ClinicalTrials.gov Identifier: NCT03429582 For Researchers ImpactTODAY Newsletters Model of Support Gateway’s Impact Funded Clinical Trials Discovery Grant Apply for a Grant Research FAQ More for you Make a Tribute Gift Read Gateway News View Clinical Trials
Miriam Cremer, MD, MPH
Cleveland Clinic Foundation
Pan Cancer
Mitochondrial-Targeted Gamitrinib for Cancer Therapy
Mitochondrial-Targeted Gamitrinib for Cancer Therapy More information to come. Trial Registration: ClinicalTrials.gov Identifier: NCT04827810 For Researchers ImpactTODAY Newsletters Model of Support Gateway’s Impact Funded Clinical Trials Discovery Grant Apply for a Grant Research FAQ More for you Make a Tribute Gift Read Gateway News View Clinical Trials
Dario Altieri, MD
The Wistar Institute
Gynecologic Cancer
Targeting adaptive changes following anti-angiogenesis therapy in ovarian cancer
Targeting adaptive changes following anti-angiogenesis therapy in ovarian cancer More information to come. Trial Registration: ClinicalTrials.gov Identifier: NCT02923739 For Researchers ImpactTODAY Newsletters Model of Support Gateway’s Impact Funded Clinical Trials Discovery Grant Apply for a Grant Research FAQ More for you Make a Tribute Gift Read Gateway News View Clinical Trials
Shannon Westin, MD, MPH, FACOG
MD Anderson Cancer Center
Prostate Cancer
Impact of Cytoreductive Radical Prostatectomy on Oncologic and Quality of Life Outcome in Men with Newly Diagnosed Metastatic Prostate Cancer
Impact of Cytoreductive Radical Prostatectomy on Oncologic and Quality of Life Outcome in Men with Newly Diagnosed Metastatic Prostate Cancer More information to come. Trial Registrations: ClinicalTrials.gov Identifier: NCT03456843 For Researchers ImpactTODAY Newsletters Model of Support Gateway’s Impact Funded Clinical Trials Discovery Grant Apply for a Grant Research FAQ More for you Make a Tribute […]
Isacc Kim, MD, PhD, MBA
Yale University
Gastrointestinal Cancer
Perioperative tadalafil and influenza vaccination in cancer patients undergoing major surgical resection of a primary abdominal malignancy
Perioperative tadalafil and influenza vaccination in cancer patients undergoing major surgical resection of a primary abdominal malignancy More information to come Trial Registration: ClinicalTrials.gov Identifier: NCT02998736 For Researchers ImpactTODAY Newsletters Model of Support Gateway’s Impact Funded Clinical Trials Discovery Grant Apply for a Grant Research FAQ More for you Make a Tribute Gift Read […]
Rebecca Auer, MD, MSc
Ottawa Hospital Research Institute, Canada
